Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.). Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.). Canadian Agency for Drugs and Technologies in Health, 2017.
Precaución: Estas citas no son 100% exactas.